Marcie A. Glicksman
Papers
1
Total Citations
3
H-Index
1
About
Marcie A. Glicksman is a pioneering researcher in neurodegenerative disease therapeutics, with a primary focus on protein misfolding disorders such as Alzheimer’s and Parkinson’s disease. Her work centers on developing innovative high-throughput screening assays to identify small-molecule inhibitors of pathological protein aggregation. Her most cited paper, “Development of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin Inhibitors” (2015, 3 citations), exemplifies her contribution to drug discovery methodology—creating robust, scalable tools to accelerate the search for treatments where none currently exist. Though her citation count is modest, Glicksman’s impact lies in laying critical groundwork for translational research; her assay design has enabled the identification of lead compounds targeting calcineurin, a key regulator in neurodegeneration. By bridging biochemistry and pharmacology, she has advanced the pipeline for therapies that could one day slow or halt diseases affecting millions. Her work underscores the importance of method innovation in tackling complex neurological disorders, inspiring students and researchers to pursue rigorous, creative approaches in drug development.
Research Focus
Key Achievements
Top Papers
- 1